These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9110393)
1. Quality of life in users of non-steroidal anti-inflammatory drugs. Hawkey CJ Scand J Gastroenterol Suppl; 1996; 221():23-4. PubMed ID: 9110393 [TBL] [Abstract][Full Text] [Related]
3. Economic and quality-of-life impact of NSAIDs in rheumatoid arthritis: A conceptual framework and selected literature review. Gabriel SE; Matteson EL Pharmacoeconomics; 1995 Dec; 8(6):479-90. PubMed ID: 10160078 [TBL] [Abstract][Full Text] [Related]
4. Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications. Peura DA Am J Med; 2004 Sep; 117 Suppl 5A():63S-71S. PubMed ID: 15478855 [TBL] [Abstract][Full Text] [Related]
6. Are rheumatoid arthritis patients more willing to accept non-steroidal anti-inflammatory drug treatment risks than osteoarthritis patients? Bagge E; Traub M; Crotty M; Conaghan PG; Oh E; Brooks PM Br J Rheumatol; 1997 Apr; 36(4):470-2. PubMed ID: 9159542 [TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Singh G; Ramey DR; Morfeld D; Shi H; Hatoum HT; Fries JF Arch Intern Med; 1996 Jul; 156(14):1530-6. PubMed ID: 8687261 [TBL] [Abstract][Full Text] [Related]
8. Results from a patient survey to assess gastrointestinal burden of non-steroidal anti-inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib. Steinfeld S; Bjørke PA Rheumatology (Oxford); 2002 Apr; 41 Supp 1():23-7; discussion 35-42. PubMed ID: 12173277 [TBL] [Abstract][Full Text] [Related]
9. Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy. Walan A; Wahlqvist P Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S79-88. PubMed ID: 10379474 [TBL] [Abstract][Full Text] [Related]
10. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines. Price-Forbes AN; Callaghan R; Allen ME; Rowe IF Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035 [TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Lazzaroni M; Bianchi Porro G Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():48-58. PubMed ID: 15335413 [TBL] [Abstract][Full Text] [Related]
12. Arthritis treatment in Hong Kong--cost analysis of celecoxib versus conventional NSAIDS, with or without gastroprotective agents. You JH; Lee KK; Chan TY; Lau WH; Chan FK Aliment Pharmacol Ther; 2002 Dec; 16(12):2089-96. PubMed ID: 12452942 [TBL] [Abstract][Full Text] [Related]
13. [The assessment of oral NSAID use in patients with rheumatoid arthritis in Hungary--a cross sectional non interventional study]. Inotai A; Rojkovich B; Mészáros A Acta Pharm Hung; 2010; 80(1):47-54. PubMed ID: 20443365 [TBL] [Abstract][Full Text] [Related]
14. Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol. Yeomans N; Wilson I; Långström G; Hawkey C; Naesdal J; Walan A; Wiklund I Scand J Rheumatol; 2001; 30(6):328-34. PubMed ID: 11846050 [TBL] [Abstract][Full Text] [Related]
16. Balancing the gastrointestinal benefits and risks of nonselective NSAIDs. Peura DA; Goldkind L Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S7-13. PubMed ID: 16168079 [TBL] [Abstract][Full Text] [Related]
17. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention. Lanas A; Ferrandez A Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792 [TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal tract disorder as a side effect of non-steroidal anti inflammatory drugs (NSAIDs). Simadibrata M Acta Med Indones; 2004; 36(4):195-6. PubMed ID: 15931719 [No Abstract] [Full Text] [Related]
19. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis. Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577 [TBL] [Abstract][Full Text] [Related]
20. The appropriate use of NSAIDs in arthritic conditions. Moskowitz RW Am J Orthop (Belle Mead NJ); 1996 Sep; 25(9 Suppl):4-6. PubMed ID: 8886211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]